b.
Termination of MCT compared to prior and subsequent therapy
| Therapy | Therapy prior to MCT | MCT | p value | Therapy subsequent to MCT | p value | |
|---|---|---|---|---|---|---|
| Patients, n | 67 | 72 | 46 | |||
| Therapy termination | PD | 62 (92.5) | 55 (76.4) | 0.255 | 28 (60.9) | 0.486 |
| Death | 0 (0.0) | 7 (9.7) | 7 (15.2) | |||
| Toxicity | 5 (7.5) | 3 (4.2) | 5 (10.9) | |||
| Low performance status | 0 (0.0) | 7 (9.7) | 5 (10.9) | |||
| Without termination | 0 (0.0) | 0 (0.0) | 1 (2.2) |
MCT, metronomic chemotherapy; CTX, cyclophosphamide; MTX, methotrexate; PD, progressive disease; CAPE, capecitabine; VRL, vinorelbine.